Teva Pharmaceutical Industries Limited 20F 2014 Q4 Annual report | TEVA Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. freshman Avg

New words: AbbVie, accommodation, Accuhaler, Adama, AdvisoryCommittee, Aegerion, Albutropin, alike, altered, andGranix, andLonquex, asTevagrastim, Balugrastimfor, Barer, bore, bronchodilator, Brooklyn, calcitonin, Cand, capecitabine, Celanese, Celgene, CGRP, Chiesi, CHMP, chose, Clara, Client, cliff, cold, Connecticut, Content, Cook, cough, decongestion, Deficiency, dialogue, disbursed, doubled, driver, Ecole, elevating, elucidation, endowment, entrepreneurial, Erickson, erosion, escrow, ethyl, exact, Expiratory, Ext, Farma, Fidelity, filled, FMR, footnote, Georgia, glycol, Greensboro, Halfon, hryvnia, immunology, impermissible, inaccurate, InCanada, includesQnasl, Indonesia, Inhalerfor, injapan, inorganic, inrussia, InspireMD, InSwitzerland, intravenously, iontophoretic, IPG, Lemtrada, lessening, Lever, linear, Lovaza, lump, lyophilized, MAA, McCann, menstrual, Metadate, MHRA, Mimvey, mindset, Municipal, nonclinical, norethindrone, Olafsson, Olmesartan, omega, PEG, Perrigo, perspective, Pharm, Philip, polyethylene, possessed, Pravachol, pravastatin, precluded, PSU, quantity, Questionnaire, Regenera, reissue, reprioritization, restitution, revert, Reykjavik, RMS, roof, routine, Santa, Settimo, Siggi, Sigurdur, sixty, SJ, solidifying, Somatropin, Soroka, spun, sublingual, sumatriptan, supersede, Swisse, synchronization, task, tenure, testosterone, tidal, Tobi, tobramycin, transparency, Trisenox, UCB, Ukrainian, underwent, Unilever, unutilized, upcoming, valuable, Vigilance, VMS, Volunteer, Worst, Xeloda

Removed: abroad, accelerating, Accutane, add, addressed, adjunctive, African, AG, Alba, Albert, alcohol, alfa, allocate, Altra, amortizing, Andromeda, anemia, anovulation, Aposense, Applisonix, appraisal, Argentina, assisted, atrophy, attained, attendance, austerity, Austria, balugrastim, Belgium, benchmarking, Bezeq, biologic, bipolar, bladder, BPCI, broader, budgetary, calcium, capture, capturing, Castle, Cenestin, Ception, chemotherapeutic, Chile, clusterin, CML, Colpotrophine, consultation, contributory, curetech, custirsen, Dafna, deal, decided, deductible, DeGroote, denial, depressive, deterrent, Deutsche, diproprionate, divested, divestiture, dominant, dominated, dosed, dysmenorrhea, Einstein, elimination, EMIA, enabled, enjoying, Entrepreneurship, erythropoietin, essentially, Estreva, estrogen, expanded, extremely, faculty, female, fertilization, fifteen, finalization, Finland, flexible, Forum, French, fungal, gained, Gemin, Genome, gynecology, Hospira, inclusion, incontinence, Infarmasa, inferior, infertility, InGermany, inhibit, inInternal, injury, interchangeable, invalidated, Isaac, isotretinoin, Itzhak, Jeremy, KGaA, kinase, Kowa, Laboratoire, Ladenburg, Leeloo, levin, Lipitor, literature, lodged, logistical, Lonza, Lutenyl, marketable, Massuot, MBA, McMaster, mediwound, menopause, Mensing, Mepha, metabolism, methodology, Monaco, Monazol, NeoRecormon, Neulasta, nonrecurring, notion, Novopharm, obatoclax, offsetting, Ohio, omacetaxine, opportunity, Orocal, OSA, overactive, oxybutynin, PA, Pacific, pan, Pelephone, Peru, Peruvian, petitioned, pharmacodynamic, phased, plasma, predominate, preempted, prescribing, progestin, prohibit, prolong, promulgated, propofol, prospectively, prostate, protecting, protein, Puerto, punitive, Quartette, randomized, rata, red, redeem, repay, reproductive, residing, Rico, Roche, Rohatyn, Rotem, SABA, Schwartz, Sellersville, shifted, Shoham, Silverfern, Slonimrejoined, SME, sNDA, Spanish, spectrum, split, stake, steering, succeeding, Suesskind, survival, SWD, Syneron, Taisho, tampering, tangible, Thalmann, theory, Theramex, tiered, transformed, treating, Trenwith, twenty, tyrosine, UK, unaudited, unbranded, urinary, variation, voluntarily, warn, Wisconsin, Yaari, Yasmin, Yaz, Zealand

Teva Pharmaceutical Industries Limited (TEVA) 20-F2014 Q4 Annual report (foreign)

Content analysis